Welcome to Dupixent.ca!
PATIENT RESOURCES
I’ve been prescribed DUPIXENT® for:
Getting Started on DUPIXENT®
A guide for people and caregivers of people with moderate-to-severe atopic dermatitis
Instructions for Use: DUPIXENT® 200 mg pre-filled syringe with needle shield
Instructions for Use: DUPIXENT® 200 mg pre-filled pen
Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield
Instructions for Use: DUPIXENT® 300 mg pre-filled pen
IMPORTANT NOTE: The DUPIXENT® pre-filled pen is not intended for use in pediatrics below 2 years of age. For children aged 6 months to 2 years of age, contact your doctor who will prescribe the appropriate DUPIXENT® pre-filled syringe. In children 6 months to less than 12 years of age, DUPIXENT® should be given by a caregiver. In children 12 years of age and older, it is recommended that DUPIXENT® be administered by or under supervision of an adult.
Getting Started on DUPIXENT®
A guide for people aged 6 years and older with severe type 2/eosinophilic or oral corticosteroid-dependent asthma
Instructions for Use: DUPIXENT® 200 mg pre-filled syringe with needle shield
Instructions for Use: DUPIXENT® 200 mg pre-filled pen
Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield
Instructions for Use: DUPIXENT® 300 mg pre-filled pen
In children 6 years to less than 12 years of age, DUPIXENT® should be given by a caregiver. In children 12 years of age and older, it is recommended that DUPIXENT® be administered by or under supervision of an adult.
Getting Started on DUPIXENT®
A guide for the treatment of adult and adolescent patients aged 12 years and older who weigh at least 40 kg with eosinophilic esophagitis (EoE)
Instructions for Use: DUPIXENT® 300 mg pre-filled syringe with needle shield
Instructions for Use: DUPIXENT® 300 mg pre-filled pen
LEARN HOW TO ADMINISTER DUPIXENT®
-
Using the pre-filled pen
-
Using the pre-filled syringe with needle shield
WE ARE YOUR CARE COMPANION
SAFETY INFORMATION
What is DUPIXENT® used for?
Atopic Dermatitis
- To treat patients aged 6 months and older with moderate-to-severe atopic dermatitis, also known as atopic eczema. DUPIXENT® can be used with or without topical corticosteroids.
- It is not known if DUPIXENT® is safe and effective in children with atopic dermatitis below the age of 6 months
Asthma
- In addition to other asthma medicines for maintenance treatment of adults, adolescents and children (6 years and older) with severe asthma with a type 2/eosinophilic phenotype or oral corticosteroid-dependent asthma, whose asthma is not controlled with their current asthma medicines
- It is not known if DUPIXENT® is safe and effective in children with asthma below the age of 6 years
- DUPIXENT® is not used to treat sudden breathing problems
Chronic Rhinosinusitis with Nasal Polyposis
- To treat adult patients with severe chronic rhinosinusitis with nasal polyposis (CRSwNP) in combination with intranasal corticosteroids, whose disease is not controlled with systemic corticosteroids or surgery
- It is not known if DUPIXENT® is safe and effective in children below the age of 18 years
Eosinophilic Esophagitis
- To treat adults and adolescent patients aged 12 years and older who weigh at least 40 kg with eosinophilic esophagitis (EoE)
Prurigo Nodularis
- To treat adult patients with moderate-to-severe prurigo nodularis (PN) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT® can be used with or without topical corticosteroids.
- It is not known if DUPIXENT® is safe and effective in children below the age of 18 years
Who should NOT use DUPIXENT®
Do not use DUPIXENT® if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.
DUPIXENT® can potentially cause serious side effects, including generalized allergic (hypersensitivity) reactions and anaphylactic reaction. You must look for signs or symptoms of these conditions (e.g., breathing problems, swelling of the face, lips, mouth, throat or tongue, fainting, dizziness, feeling lightheaded (low blood pressure), fever, general ill feeling, swollen lymph nodes, hives, itching, joint pain, skin rash) while you are taking DUPIXENT®. Stop taking DUPIXENT® and tell your doctor or seek medical help immediately if you notice any signs or symptoms of an allergic reaction.
DUPIXENT® is not a rescue medicine and should not be used to treat a sudden asthma attack.
Do not stop or reduce your asthma medicines, unless instructed by your doctor. These medicines (especially ones called corticosteroids) must be stopped gradually, under the direct supervision of your doctor. Rarely, patients taking DUPIXENT® may develop inflammation of blood vessels or lungs due to an increase of certain white blood cells (eosinophilia). This usually, but not always, happens in people who also take corticosteroids, which are being stopped or for which the dose is being lowered. Tell your healthcare professional immediately if you develop a combination of symptoms such as a persistent fever, shortness of breath, chest pain, rash, and/or pins and needles or numbness of arms or legs.
What should I tell my doctor before taking DUPIXENT®?
To help avoid side effects and ensure proper use, talk to your healthcare provider before you take DUPIXENT®. Talk about any health conditions or problems you may have, including if you:
- Have a parasitic infection (intestinal parasites). If you already have a parasitic infection, it should be treated before you start treatment with DUPIXENT®. If you live in a region where these infections are common or if you are travelling to such a region, check with your doctor.
- Are pregnant or plan to become pregnant. It is not known if DUPIXENT® will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking DUPIXENT®.
- Are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will take DUPIXENT® or breastfeed. You should not do both without talking to your healthcare provider first.
- Have other allergic conditions such as asthma and are taking asthma medicines
- Are scheduled to receive a vaccination
- Have eye problems (e.g., itching, redness)
You should also tell your doctor about all the medicines you take, including any drugs, vitamins, minerals, natural supplements, or alternative medicines.
DUPIXENT® and Sanofi logos are trademarks of Sanofi, used under license by sanofi-aventis Canada Inc.
REGENERON® is a trademark of Regeneron Pharmaceuticals, Inc. All rights reserved.
© 2024 sanofi-aventis Canada Inc. All rights reserved.
MAT-CA-2400503E-1.0 - 09/2024
Important Note
This website is intended for educational purposes and is in no way intended to substitute for professional medical advice, to contradict medical advice given, or for medical care of any kind. As with any medication, speak to your doctor before using. Please review the Terms & Conditions before using this website. Your use of this website indicates your agreement to be bound by the Terms & Conditions.